🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Observational Study for Left Main Disease Treatment

Recruitingn/aAges 18 Years - anyAllSeung-Jung Park
NCT01341327 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to observe clinical courses for long-term in patients with unprotected LMCA disease and to evaluate comparative results of medical treatment, coronary stenting with drug-eluting stents, and CABG for the treatment of an unprotected LMCA stenosis in the "real world" daily practice.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Significant unprotected left main stenosis (\>50% by visual estimation) * The LMCA is considered unprotected if there are no patent coronary artery bypass grafts to the left anterior descending artery or the left circumflex artery. * No limitation of clinical or lesion characteristics * Age \>18 years * The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site. Exclusion Criteria: * Protected left main stenosis
💊

What it tests

  • Not listed
📍

Where

42 sites
Zhongshan Hospital
Shanghai, China
Sarawak General Hospital
Kuching, Malaysia
Hallym University medical center
Anyang, South Korea
Soonchunhyang University Hospital, Buchen
Bucheon-si, South Korea
The Catholic University of Korea, Bucheon ST.Mary's Hospital
Bucheon-si, South Korea
Inje University Busan Paik Hospital
Busan, South Korea
Soonchunhyang University Hospital, Cheonan
Cheonan, South Korea
St.Mary's Catholic Medical Center
Cheongju-si, South Korea

…and 34 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy